TNFSF10 and myeloid sarcoma: Other lines of evidence suggest that genetic variants of the TRAIL and TRAIL-receptor genes may be associated with MS susceptibility as reported by studies considering different single-nucleotide polymorphisms and splice variants in different cohorts of patients [101–103].